Clinical trials
Phase 2 Anemia, Sickle Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Forma Therapeutics, Inc. | 2 |
| HemaQuest Pharmaceuticals Inc. | 2 |
| Afimmune | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Bausch Health Americas, Inc. | 1 |
| Biossil Inc. | 1 |
| Cephalon | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 21 |
| Anemia, Hemolytic | 3 |
| Hematologic Diseases | 3 |
| Hemoglobinopathies | 3 |
| beta-Thalassemia | 3 |
| Anemia | 2 |
| Genetic Diseases, Inborn | 2 |
| Iron Overload | 2 |
| Vaso-Occlusive Crises | 2 |
| Anemia, Hemolytic, Congenital | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.